Rich Miller, a leading expert in aging research and Director at the University of Michigan’s Center for Aging Research, shares groundbreaking insights from the Interventions Testing Program (ITP). He reveals successful longevity drugs like rapamycin and the surprising failures of others, such as metformin. The conversation dives deep into aging biomarkers, highlighting their significance in understanding longevity. Miller also discusses the future of translating findings from mouse models to human applications, offering an optimistic vision for age-related research.

Michael McKee and Rich Miller analyze ECB rate cuts and US jobs data, while Laura Nahmias and Michelle Kaske discuss NY Gov halting Manhattan driving charges. Rodney Rodgers talks about a $121 million gift to BGSU for student graduation. Martín Escobar drives to close with General Atlantic.